CVS Health Corporation (CVS) disclosed fourth-quarter revenue and adjusted earnings that surpassed expectations, driven by strength in its health services business. However, concerns about towering medical costs prompted the company to slash its full-year profit outlook for 2024.

Despite the steady financial performance, CVS tightened its adjusted earnings forecast for 2024 to at least $8.30 per share, down from a previous guidance of at least $8.50 per share. This adjustment takes place amid a backdrop of soaring medical expenses that have been constraining the broader insurance industry, including health insurance giant Aetna, owned by CVS.